AMTD, Owner of L’Officiel and AMTD IDEA Brands, Launches Litigation against Jalou Family for Malicious Falsehood, Defamation, and Consequential Loss and Damage
PARIS, LONDON and NEW YORK, Jan. 15, 2026 /PRNewswire/ -- AMTD Group…
AMTD, Owner of The Art Newspaper, Launches Litigation against INNA BAZHENOVA and GLEB IBRAGIMOV for Intimidation, Malicious Falsehood, Breach of Confidence and Consequential Loss and Damage
PARIS and NEW YORK and LONDON, Jan. 15, 2026 /PRNewswire/ -- AMTD…
AquaFit Weight Loss Supplement Investigation: 2026 Thermogenic Research Examines Green Tea, Berberine, and Metabolic Support Ingredients
AURORA, COLORADO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is…
Best Chocolate Weight Loss Supplement: Consumer Analysis Examines Cacao GLP-1 Research as January Wellness Interest Surges
BOULDER, CO, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is…
Best Weight Loss Pills for 2026? FDA Approves First Oral GLP-1 as Patients Evaluate Wegovy, Zepbound, and Telehealth Access Pathways
Newark, DE, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The term "best" reflects…
How Does Ozempic Work For Weight Loss? Best Weight Loss Supplement Launch By PhenQ
New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Maintaining a…
Best Semaglutide For Weight Loss 2026: Is MEDVi the Best GLP-1 Supplier for a Sustainable Online Weight Loss Program?
New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Intro As…
Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts
Bluffdale, Dec. 26, 2025 (GLOBE NEWSWIRE) -- As millions of Americans enter…
What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives
LAKELAND, Dec. 20, 2025 (GLOBE NEWSWIRE) -- This educational analysis is sponsored…
Is MEDVi the Best GLP-1 Supplier for 2026? Platform Lists Compounded Semaglutide at $179/Month With No Contract Ahead of Weight Loss Season
Los Angeles, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Important Information for Readers:…
